The reason? CVS is more diversified—they operate retail pharmacies (9,000 locations), Pharmacy Benefit Management (CVS ...

The diversified healthcare company reports earnings next month.

CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

As CVS Health has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the ...

Nonetheless, its LTM Revenue Growth of 10% is lower than Centene’s 15%, indicating a robust, mature foundation with constrained near-term potential in a fluid ...

CVS Health CVS is scheduled to report third-quarter 2025 results on Oct. 29, before the market opens. The Zacks Consensus Estimate for third-quarter earnings per share (EPS) suggests a 24.8% increase ...

CVS Health Corporation is rated a Buy with an 18% upside to a $97 price target, citing robust business momentum and undervaluation. CVS posted a strong FQ2 2025 double-beat, with revenue up 8.4% and ...

With CVS reestablishing forward guidance and offering a deeply discounted valuation, the balance of risk favors upside.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...